Method of reducing food intake in a healthy mammal
AssigneeTeagasc, The Agriculture and Food Development Authority
InventorsSinead Bleiel, Robert Kent, Neil Gerard Docherty, Carel Wynand Le Roux
Life of this patent
Estimating the term…
Abstract
A therapeutic or non-therapeutic method of inducing satiety in a mammal is described. The method comprises administering to the mammal a composition comprising microparticles, in which the microparticles comprise lipid contained within a gastric-resistant, ileal-sensitive, carrier configured for release of the lipid in the ileum, wherein the composition is administered 1-3 hours prior to a meal. The carrier is a protein, typically denatured or hydrolysed plant or dairy protein, that is polymerised to form a lipid containing shell or matrix.
Claims14
A method of reducing food intake in a healthy mammal in need of reducing food intake, the method comprising administering to the healthy mammal an oral composition comprising gut peptide hormone response-generating microparticles, in which the microparticles comprise lipid contained within a gastric-resistant, ileal-sensitive carrier, wherein the composition is orally administered 1-3 hours prior to a meal, and in which the carrier comprises a double-coating of denatured crosslinked plant or dairy protein configured for distal bowel release, and wherein administering the composition to the healthy mammal generates a gut peptide hormone response, thereby reducing food intake in the healthy mammal.
A method of reducing food intake in a healthy mammal in need of reducing food intake, the method comprising administering to the healthy mammal an oral composition comprising gut peptide hormone response-generating microparticles, in which the microparticles comprise lipid contained within a gastric-resistant, ileal-sensitive carrier, wherein the composition is orally administered 1-3 hours prior to a meal, and in which the carrier comprises a double-coating of denatured crosslinked plant or dairy protein configured for distal bowel release, wherein administering the composition to the healthy mammal generates a gut peptide hormone response, thereby reducing food intake in the healthy mammal and wherein the microparticles are formed by a method comprising the steps of:
- providing solid lipid microparticles on a fluidised bed;
- spraying a denatured protein solution onto the bed to coat the lipid particles and form microparticles;
- and
- drying the microparticles,
- wherein a second denatured protein solution is sprayed on to the dried microparticles.
Dependencies are inferred from the claim text.